American Healthcare REIT Inc (NYSE:AHR)

Q3 2025 American Healthcare REIT Inc Earnings Call Transcript

Nov 7, 2025 / 06:00 PM GMT

Release Date Price: $49.42 (+3.13%)

Transcript 10-Q8-K

Key Points

Positve

American Healthcare REIT Inc (AHR) reported a strong third quarter with a 16.4% same-store NOI growth across its total portfolio, marking the seventh consecutive quarter of double-digit growth.
The company has successfully closed over $575 million in acquisitions year-to-date, expanding its operating portfolio and introducing two new operator relationships.
AHR's strategy of leveraging its platform and regional operating partners has resulted in same-store occupancies above 90% for its Trilogy and Shop segments.
The company is on track to grow normalized FFO per fully diluted share by 20% over last year, with a net debt to EBITDA ratio reduced to 3.5 times.
AHR published its inaugural corporate responsibility report, highlighting its commitment to governance, social, and sustainability priorities.

Negative

There is a potential for seasonality to impact occupancy rates in the fourth quarter, particularly during the holiday season.
Medicare reimbursement rates are expected to grow at a slower pace compared to the previous year, which could pose a growth headwind.
The company faces challenges in maintaining margins due to factors such as flu vaccine purchases and employee health insurance costs.
Despite strong performance, there is uncertainty about the maximum occupancy upside and pricing strategy as the company approaches full capacity.
The competitive environment for acquisitions remains challenging, with potential increases in asset pricing as the market for senior housing continues to perform well.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AHR.N - American Healthcare REIT Inc
Q3 2025 American Healthcare REIT Inc Earnings Call
Nov 07, 2025 / 06:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, thank you for standing by. My name is Colby and I'll be your conference operator today. At this time, I would like to welcome you to the American Healthcare RAT Q3 2025 earnings conference call.

All lines have been placed on mute to prevent any background noise, and after the speaker's remarks, there will be a question-and-answer session.

We please ask that you limit yourself to one question and one follow-up.

Thank you.

If you'd like to ask a question at that time, please press star, then the number 1 on your telephone keypad.

If you'd like to withdraw your question at any time, please press 1 again.

I would now like to turn the call over

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.